Cite
HARVARD Citation
Gu, L. et al. (2022). Durable response to low-dose pralsetinib in a renal insufficient patient with NSCLC harboring concurrent CCDC6-RET, LINCO1264-RET, and SEMA5A-RET fusions: A case report. Medicine. 101 (47), pp. e31480-. [Online].